Y-mAbs Therapeutics
YMAB
#8054
Rank
โ‚น17.40 B
Marketcap
โ‚น384.85
Share price
-3.43%
Change (1 day)
-67.99%
Change (1 year)

Revenue for Y-mAbs Therapeutics (YMAB)

Revenue in 2024 (TTM): โ‚น7.38 Billion

According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น7.49 Billion. an increase over the revenue in the year 2023 that were of โ‚น7.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Y-mAbs Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น7.52 B6.53%
2023 โ‚น7.06 B30.74%
2022 โ‚น5.40 B107.93%
2021 โ‚น2.59 B71.16%
2020 โ‚น1.51 B
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA